Madrigal Pharmaceuticals (MDGL) Operating Leases (2019 - 2025)
Historic Operating Leases for Madrigal Pharmaceuticals (MDGL) over the last 7 years, with Q3 2025 value amounting to $5.6 million.
- Madrigal Pharmaceuticals' Operating Leases rose 37329.93% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 37329.93%. This contributed to the annual value of $1.0 million for FY2024, which is 1416.53% down from last year.
- Madrigal Pharmaceuticals' Operating Leases amounted to $5.6 million in Q3 2025, which was up 37329.93% from $4.5 million recorded in Q2 2025.
- Madrigal Pharmaceuticals' Operating Leases' 5-year high stood at $5.6 million during Q3 2025, with a 5-year trough of $71000.0 in Q3 2022.
- For the 5-year period, Madrigal Pharmaceuticals' Operating Leases averaged around $1.2 million, with its median value being $825000.0 (2024).
- As far as peak fluctuations go, Madrigal Pharmaceuticals' Operating Leases plummeted by 8553.97% in 2022, and later surged by 176338.03% in 2023.
- Over the past 5 years, Madrigal Pharmaceuticals' Operating Leases (Quarter) stood at $387000.0 in 2021, then tumbled by 81.65% to $71000.0 in 2022, then surged by 1570.42% to $1.2 million in 2023, then decreased by 14.17% to $1.0 million in 2024, then skyrocketed by 446.76% to $5.6 million in 2025.
- Its Operating Leases was $5.6 million in Q3 2025, compared to $4.5 million in Q2 2025 and $750000.0 in Q1 2025.